Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Akero Therapeutics, Inc. (AKRO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.34-0.74 (-3.35%)
At close: 4:00PM EDT
21.34 0.00 (0.00%)
After hours: 04:33PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close22.08
Open22.34
Bid20.00 x 900
Ask28.00 x 800
Day's Range21.20 - 22.34
52 Week Range17.66 - 34.87
Volume135,581
Avg. Volume183,718
Market Cap743.189M
Beta (5Y Monthly)0.51
PE Ratio (TTM)N/A
EPS (TTM)-2.49
Earnings DateAug 10, 2021 - Aug 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est56.71
  • GlobeNewswire

    Akero Therapeutics to Present at the H.C. Wainwright 5th Annual NASH Investor Conference

    SOUTH SAN FRANCISCO, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH), today announced that Tim Rolph, Akero’s Chief Scientific Officer and Co-Founder, will present at the H.C. Wainwright 5th Annual NASH Investor Conference on Tuesday, October 12, 2021 at 12:00 p.m. (ET). A live webcast of the Company presentation will be available through the

  • Simply Wall St.

    Here's Why We're Not Too Worried About Akero Therapeutics' (NASDAQ:AKRO) Cash Burn Situation

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

  • GlobeNewswire

    Akero Therapeutics to Present at the Morgan Stanley Virtual Global Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH), today announced that members of the management team will present at the Morgan Stanley Virtual Global Healthcare Conference on Wednesday, September 15, 2021 at 11:45 a.m. (ET). A live webcast of the Company presentation will be available through the investor relations sect

Advertisement
Advertisement